Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Pregnancy With Insomnia: a Trial of Acupuncture (GAS)

27. juni 2017 opdateret af: Assistance Publique - Hôpitaux de Paris

Acupuncture is widely used for treatment of insomnia. The research hypothesis is that acupuncture may be more effective than sham acupuncture to treat insomnia during pregnancy.

GAS is a randomized controlled trial with placebo acupuncture using the insomnia severity index (ISI) as the main outcome criterion.

Studieoversigt

Status

Ukendt

Betingelser

Intervention / Behandling

Detaljeret beskrivelse

Scientific justification:

- During pregnancy, insomnia occurs mainly in women without a previous history of sleep disorder, and may remain after delivery. Insomnia affects the quality of life. It might be associated with an increase in labor duration and cesarean section rate.

Insomnia tends to worsen during gestation, owing to back pain, an increased need to micturate, and the movement of the fetus. Sleep disorders are often associated with restless legs syndrome.

  • To treat insomnia during pregnancy, the Haute Autorité de Santé (HAS) recommends avoiding using psychotropic medications. It also recommends screening for depression or anxiety traits often associated with insomnia. However, in most cases, psychological means alone fail to treat insomnia effectively.
  • Based on 11 randomized controlled trials, the odds of improving sleep disorders are 3 times greater with than without acupuncture, but the methodological quality of these trials is considered insufficient to conclude.

Population:

The study focused on pregnant women suffering from insomnia, excluding women with pregnancies complicated by pre-eclampsia, fetal growth anomalies, or threatened premature labor for fear those complications might interact with sleep disorders, as well as women with known psychiatric disorders. We also excluded women with a history of insomnia before pregnancy to focus on insomnia triggered by pregnancy only.

Objectives:

  • Primary objective: To assess the effect of a standardized acupuncture protocol vs. placebo on insomnia during pregnancy.
  • Secondary objectives: To assess the effect of a standardized acupuncture protocol vs. placebo on (i) the Pittsburgh Sleep Quality Index (PSQI), (ii) anxiety and depression traits, (iii) use of psychotropic medicines and (iv) recreational substances, (v) the incidence of restless legs syndrome, (vi) perinatal outcome .

Study design:

  • Study Type: Multicentre, Interventional, randomized, 2 parallel groups
  • Endpoint Classification: Efficacy Study
  • Intervention Model: Parallel Assignment
  • Masking: Single blind (patient blinded to intervention)
  • Primary Purpose: Treatment
  • One acupuncture session weekly for 4 consecutive weeks

Visits:

  • Selection: When a pregnant woman complains from insomnia, the health professional in charge will fill a checklist of inclusion and exclusion criteria, provide the patient with a pre inclusion ISI questionnaire and give the patient an information sheet and a copy of the consent. When a pregnant woman is sent to the acupuncturist for sleep disorders, he or she may proceed to the selection visit.
  • Inclusion: The acupuncturist checks for inclusion and exclusion criteria, collects the patient written consent, performs the clinical examination, gives the corresponding self-assessment questionnaires and proceeds to computerized randomization.
  • Follow-up: At visits 1 to 4, the acupuncturist performs the treatment, and records side effects if any. Visits are scheduled on a weekly basis.
  • End of research: At visit 5 (one week after last acupuncture session), the acupuncturist gives the corresponding self-assessment questionnaires.

Undersøgelsestype

Interventionel

Tilmelding (Forventet)

60

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år og ældre (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Kvinde

Beskrivelse

Inclusion Criteria:

  • Age > 18 years
  • Singleton pregnancy
  • Gestational age ≥ 16 weeks + 0 day and ≤ 32 weeks + 6 days
  • Insomnia Severity Index ≥ 10
  • Insomnia reported to have started during pregnancy and at least 2 weeks before inclusion
  • Patient understanding the study
  • Informed consent signed
  • Social insurance available at inclusion and until the end of pregnancy

Exclusion Criteria:

  • Threatened premature labor
  • Small fetus for gestational age
  • Pre-eclampsia
  • Insomnia starting before pregnancy
  • Use of psychotropic drugs before pregnancy
  • Use of recreational drugs during pregnancy
  • Known psychiatric disorder
  • Anticoagulant therapy
  • Patient reporting insomnia results from chronic or acute pain
  • Obstructive sleep apnea (OSA) requiring treatment
  • Patient under antidepressant therapy
  • Patient under legal guardianship or deprived of freedom

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Behandling
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Enkelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Regular acupuncture needles
Real acupuncture procedure The real acupuncture will be performed by means of standard stainless-steel needles (0.30-mm diameter, 30-mm length/Gauge 8 x 1.2"), located bilaterally in 5 real acupoints.
The patient will be in a semi recumbent position during needle penetration. Duration of needle insertion: 30 minutes
Sham-komparator: Sham acupuncture needles
Sham acupuncture with a no penetrating sham needle (blunt and telescopic), giving the impression of insertion but without penetrating the skin will be placed bilaterally in 5 false acupoints
The patient will be in a semi recumbent position during needle penetration. Duration of needle insertion: 30 minutes

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Insomnia severity index (ISI)
Tidsramme: Inclusion visit and 5 weeks after the first acupuncture session
Difference of ISI self-report questionnaire administrated at inclusion visit and 5 weeks after the first acupuncture session
Inclusion visit and 5 weeks after the first acupuncture session

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Pittsburgh Sleep Quality Index (PSQI)
Tidsramme: Inclusion visit and 5 weeks after the first acupuncture session
Difference of PSQI self-report questionnaire administrated at inclusion visit and 5 weeks after the first acupuncture session
Inclusion visit and 5 weeks after the first acupuncture session
Hospital Anxiety and Depression Scale (HADS)
Tidsramme: Inclusion visit and 5 weeks after the first acupuncture session
Difference of HADS self-report questionnaire administrated at inclusion visit and 5 weeks after the first acupuncture session
Inclusion visit and 5 weeks after the first acupuncture session
Cumulated dose of each psychotropic medicine
Tidsramme: Inclusion visit and 5 weeks after the first acupuncture session
During the study period, the patients will note on a logbook the daily use of any drug.
Inclusion visit and 5 weeks after the first acupuncture session
Cumulated dose of alcohol
Tidsramme: Inclusion visit and 5 weeks after the first acupuncture session
During the study period, the patients will note on a logbook the daily use of alcohol.
Inclusion visit and 5 weeks after the first acupuncture session
Cumulated dose of tobacco
Tidsramme: Inclusion visit and 5 weeks after the first acupuncture session
During the study period, the patients will note on a logbook the daily use of tobacco.
Inclusion visit and 5 weeks after the first acupuncture session
Cumulated dose of cannabis
Tidsramme: Inclusion visit and 5 weeks after the first acupuncture session
During the study period, the patients will note on a logbook the daily use of cannabis.
Inclusion visit and 5 weeks after the first acupuncture session
Cumulated dose of other recreational substances or medicine
Tidsramme: Inclusion visit and 5 weeks after the first acupuncture session
During the study period, the patients will note on a logbook the daily use of other recreational substances and medicine.
Inclusion visit and 5 weeks after the first acupuncture session
Difference in the frequency of restless leg syndrome
Tidsramme: Inclusion visit and 5 weeks after the first acupuncture session

According to the guidelines of the International Restless Legs Syndrome Study Group.

The diagnosis of restless leg will rely on the presence of all of the following criteria:

  1. Desire to move the extremities usually associated with discomfort or disagreeable sensations in the extremities.
  2. Motor Restlessness-patients move to relieve the discomfort, for example walking, or to provide a counter-stimulus to relieve the discomfort, for example, rubbing the legs.
  3. Symptoms are worse at rest with at least temporary relief by activity.
  4. Symptoms are worse later in the day or at night.
Inclusion visit and 5 weeks after the first acupuncture session
Perinatal outcome - Gestational age at birth
Tidsramme: At birth
The gestational age at birth of the newborn will be recorded.
At birth
Perinatal outcome - birth weight
Tidsramme: At birth
The weight (in gr) at birth of the newborn will be recorded.
At birth
Perinatal outcome - birth height
Tidsramme: At birth
The height (in cm) at birth of the newborn will be recorded.
At birth
Perinatal outcome - sex
Tidsramme: At birth
The sex of the newborn will be recorded.
At birth
Perinatal outcome - perinatal mortality
Tidsramme: At birth
The perinatal mortality will be recorded.
At birth
Perinatal outcome - five minutes Apgar score
Tidsramme: At birth
The five minutes Apgar score will be recorded.
At birth
Perinatal outcome - cesarean section rate
Tidsramme: At birth.
Cesarean section rate will be recorded.
At birth.

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Efterforskere

  • Ledende efterforsker: Stéphanie Nicolian, Midewife, Assistance Publique - Hôpitaux de Paris

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Forventet)

1. september 2017

Primær færdiggørelse (Forventet)

1. januar 2019

Studieafslutning (Forventet)

1. maj 2019

Datoer for studieregistrering

Først indsendt

23. maj 2017

Først indsendt, der opfyldte QC-kriterier

19. juni 2017

Først opslået (Faktiske)

21. juni 2017

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

28. juni 2017

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

27. juni 2017

Sidst verificeret

1. april 2017

Mere information

Begreber relateret til denne undersøgelse

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

Ingen

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

produkt fremstillet i og eksporteret fra U.S.A.

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Kliniske forsøg med Søvnløshed

Abonner